Skip to content

Elanco Animal Health

US · ELAN #1381 by market cap Listed 2018
25.74 -0.55 -2.09%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions increased by 12 in the most recent period (2026/Q3).
  • Total institutional ownership fell 2.4 percentage points.

Ownership vs. money flow

Diverging

Institutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
111.90% -2.42pp
Institutions
621 +12
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund99.25%
Hedge Fund6.91%
Public Company3.09%
Government Pension Fund1.08%
Individual/Insider0.71%
Private Company0.70%
Insurance Company0.37%
Family Office/Trust0.24%
Government0.13%

Top holders as of 2026-09-30

Dodge & Cox 12.29% · 61.43M sh
FMR 11.86% · 59.28M sh
BlackRock 9.86% · 49.28M sh
PRIMECAP Management Company 9.09% · 45.45M sh
T. Rowe Price Group, Inc. 6.03% · 30.13M sh
Dimensional Fund Advisors 5.02% · 25.07M sh
Vanguard Portfolio Management, LLC 4.62% · 23.09M sh
Vanguard Capital Management, LLC 4.51% · 22.54M sh
State Street Global Advisors 3.26% · 16.29M sh
Winslow Capital Management, LLC 2.70% · 13.51M sh
Black Creek Investment Management Inc. 2.68% · 13.39M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 48 buys · 2 sells

NameRoleStake
Jeffrey Simmons Chief Executive Officer 0.37%
Ramiro Cabral Executive VP & President of Elanco International 0.04%
Ellen de Brabander Executive Vice President of Research, Development & Regulatory Affairs 0.04%
David Kinard Former Executive Vice President of Human Resources, Communications & Administration 0.04%
Roy Hoover Former Independent Director 0.04%
Rajeev Modi Executive Vice President of U.S. Pet Health & Global Digital Transformation 0.03%
Grace McArdle Executive Vice President of Manufacturing & Quality 0.02%
Timothy Bettington Executive Vice President of Center of Strategic Growth 0.02%
Shiv O'Neill Executive Vice President, General Counsel & Corporate Secretary 0.02%
Todd Young Former Chief Financial Officer 0.02%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-10-29 Jeffrey Simmons Chief Executive Officer Other Derivative Acquisition +122 --
2026-10-29 Robert VanHimbergen Chief Financial Officer Other Derivative Acquisition +8 --
2026-10-29 Rajeev Modi Executive Vice President of U.S. Pet Health & Global Digital Transformation Other Derivative Acquisition +64 --
2026-10-15 Jeffrey Simmons Chief Executive Officer Other Derivative Acquisition +120 --
2026-10-15 Robert VanHimbergen Chief Financial Officer Other Derivative Acquisition +8 --
2026-10-15 Rajeev Modi Executive Vice President of U.S. Pet Health & Global Digital Transformation Other Derivative Acquisition +62 --
2026-10-14 Timothy Bettington Executive Vice President of Center of Strategic Growth Automatic Disposition -4,350 $23.00
2026-10-14 Timothy Bettington Executive Vice President of Center of Strategic Growth Intent to Sell (Form 144) -4,350 $23.00
2026-10-01 Jeffrey Simmons Chief Executive Officer Other Derivative Acquisition +127 --
2026-10-01 Robert VanHimbergen Chief Financial Officer Other Derivative Acquisition +8 --
2026-10-01 Rajeev Modi Executive Vice President of U.S. Pet Health & Global Digital Transformation Other Derivative Acquisition +66 --
2026-09-29 Kapila Anand Independent Director Other Derivative Acquisition +642 --
2026-09-17 Jeffrey Simmons Chief Executive Officer Other Derivative Acquisition +126 --
2026-09-17 Robert VanHimbergen Chief Financial Officer Other Derivative Acquisition +8 --
2026-09-17 Rajeev Modi Executive Vice President of U.S. Pet Health & Global Digital Transformation Other Derivative Acquisition +65 --
2026-09-03 Jeffrey Simmons Chief Executive Officer Other Derivative Acquisition +115 --
2026-09-03 Robert VanHimbergen Chief Financial Officer Other Derivative Acquisition +8 --
2026-09-03 Rajeev Modi Executive Vice President of U.S. Pet Health & Global Digital Transformation Other Derivative Acquisition +60 --
2026-08-20 Jeffrey Simmons Chief Executive Officer Other Derivative Acquisition +117 --
2026-08-20 Robert VanHimbergen Chief Financial Officer Other Derivative Acquisition +8 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 20:02:31 · For reference only, not investment advice and not tailored to your situation.

Elanco Animal Health discussion 0 comments

Add a comment